Ascendis Pharma A/S (ASND) Stock Forecast
Data as of Aug 5, 2026Healthcare · Current price $243.46 (+0.00%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
ASND vs Sector & Market
| Metric | ASND | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.25 | 2.42 |
| Analyst Count | 8 | 8 | 18 |
| Target Upside | +18.9% | +16316.2% | +17.1% |
| P/E Ratio | -51.06 | 3.37 | 36.31 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $337M | $371M | $406M | 4 |
| 2026-12-31 | $382M | $421M | $460M | 7 |
| 2027-03-31 | $386M | $424M | $464M | 4 |
| 2027-06-30 | $410M | $451M | $494M | 6 |
| 2027-09-30 | $444M | $489M | $535M | 4 |
| 2027-12-31 | $488M | $536M | $587M | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $1.11 | $1.26 | $1.42 | 3 |
| 2026-12-31 | $1.52 | $1.73 | $1.94 | 6 |
| 2027-03-31 | $1.38 | $1.56 | $1.75 | 3 |
| 2027-06-30 | $1.55 | $1.76 | $1.97 | 5 |
| 2027-09-30 | $1.84 | $2.08 | $2.34 | 3 |
| 2027-12-31 | $2.25 | $2.55 | $2.87 | 6 |
Frequently Asked Questions
What is the analyst consensus for ASND?
The consensus among 8 analysts covering Ascendis Pharma A/S (ASND) is Buy with an average price target of $287.50.
What is the highest price target for ASND?
The highest analyst price target for ASND is $345.00.
What is the lowest price target for ASND?
The lowest analyst price target for ASND is $250.00.
How many analysts cover ASND?
8 analysts have issued ratings for Ascendis Pharma A/S in the past 12 months.
Is ASND a buy or sell right now?
Based on 8 analyst ratings, ASND has a consensus rating of Buy (2.00/5) with a +18.9% upside to the consensus target of $287.50.
What are the earnings estimates for ASND?
Analysts estimate ASND will report EPS of $1.26 for the period ending 2026-09-30, with revenue estimated at $371M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.